Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2011 | OriginalPaper | Hoofdstuk

5. Genderspecifieke Aspecten van Hartritmestoornissen

Auteurs: Drs. Lieve van Casteren, Dr. Arif Elvan, Drs. Amber Otten, Drs. Bernadette van Casteren

Gepubliceerd in: Handboek gynaecardiologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Wereldwijd is er een toenemende aandacht voor hartritmestoornissen, enerzijds omdat de bevolking ouder wordt, anderzijds omdat klachten vaker gemeld worden en er duidelijke verbeteringen zijn in de behandeling daarvan. Door een effectievere behandeling van het acuut coronair syndroom (ACS) is de prevalentie van ventriculaire ritmestoornissen veel lager geworden, maar omdat patiënten uiteindelijk vaak hartfalen krijgen en langer leven komen daar weer andere ritmeproblemen voor terug.
Literatuur
1.
go back to reference Liu K, Ballew C, Jr DR, Sidney S, Savage PJ, Dyer A, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 1989; 14: 218–26. PubMedCrossRef Liu K, Ballew C, Jr DR, Sidney S, Savage PJ, Dyer A, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 1989; 14: 218–26. PubMedCrossRef
2.
go back to reference Kadish AH. The effect of gender on cardiac electrophysiology and arrhythmias. In: Zipes DP, Jaliffe J, eds. Cardiac Electrophysiology: From cell to bedside; 2nd ed. Philadelphia (Penn): Saunders, 1995; 1268–75. Kadish AH. The effect of gender on cardiac electrophysiology and arrhythmias. In: Zipes DP, Jaliffe J, eds. Cardiac Electrophysiology: From cell to bedside; 2nd ed. Philadelphia (Penn): Saunders, 1995; 1268–75.
3.
go back to reference Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997; 79: 178–81. PubMedCrossRef Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997; 79: 178–81. PubMedCrossRef
4.
go back to reference Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: the Women’s Health Initiative. Circulation 2006; 113: 481–89. PubMedCrossRef Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: the Women’s Health Initiative. Circulation 2006; 113: 481–89. PubMedCrossRef
5.
go back to reference Rautaharja P, Zhou S, Wong S, Calhoun H, Berenson G, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690–95. Rautaharja P, Zhou S, Wong S, Calhoun H, Berenson G, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690–95.
6.
go back to reference Verkerk AO, Wilders R, Tan HL. Gender disparities in torsade de pointes ventricular tachycardia. Neth Heart J 2007; 15: 405–11. PubMedCrossRef Verkerk AO, Wilders R, Tan HL. Gender disparities in torsade de pointes ventricular tachycardia. Neth Heart J 2007; 15: 405–11. PubMedCrossRef
7.
go back to reference Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadisch AH. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996; 100: 537–43. PubMedCrossRef Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadisch AH. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996; 100: 537–43. PubMedCrossRef
8.
go back to reference Rautaharju PM, Surawics B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. J Am Coll Cardiol 2009; 53: 981–91. CrossRef Rautaharju PM, Surawics B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. J Am Coll Cardiol 2009; 53: 981–91. CrossRef
9.
go back to reference Liuba I, Jönsson A, Safström K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97: 1645–49. CrossRef Liuba I, Jönsson A, Safström K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97: 1645–49. CrossRef
10.
go back to reference Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993; 72: 838–40. PubMedCrossRef Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993; 72: 838–40. PubMedCrossRef
11.
go back to reference Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003; 42: 1103–7. PubMedCrossRef Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003; 42: 1103–7. PubMedCrossRef
12.
go back to reference Deneke T, Mügge A, Müller P, Groot J de. Therapeutic implications of gender differences in supraventricular cardiac arrhythmias: lessons of life cannot be learned in a day. Expert Rev Cardiovasc Ther 2009; 7: 879–82. PubMedCrossRef Deneke T, Mügge A, Müller P, Groot J de. Therapeutic implications of gender differences in supraventricular cardiac arrhythmias: lessons of life cannot be learned in a day. Expert Rev Cardiovasc Ther 2009; 7: 879–82. PubMedCrossRef
13.
go back to reference Liu S, Yuan S, Hertervig E, Kongstad O, Olsson SB. Gender and atrioventriculaire conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 2001; 34: 295–301. PubMedCrossRef Liu S, Yuan S, Hertervig E, Kongstad O, Olsson SB. Gender and atrioventriculaire conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 2001; 34: 295–301. PubMedCrossRef
14.
go back to reference Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm 2005; 2: 1277-82. PubMedCrossRef Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm 2005; 2: 1277-82. PubMedCrossRef
15.
go back to reference Schulze-Bahr E, Kirchhoff P, Eckardt L, Bertrand J, Breithardt G. Gender differences in cardiac arrhythmias. Herz 2005; 30: 390–400. PubMedCrossRef Schulze-Bahr E, Kirchhoff P, Eckardt L, Bertrand J, Breithardt G. Gender differences in cardiac arrhythmias. Herz 2005; 30: 390–400. PubMedCrossRef
16.
go back to reference Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Study. JAMA 1994; 271: 840–44. PubMedCrossRef Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Study. JAMA 1994; 271: 840–44. PubMedCrossRef
17.
go back to reference Feinberg WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469–73. PubMedCrossRef Feinberg WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469–73. PubMedCrossRef
18.
go back to reference Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 2002; 53: 678–87. PubMedCrossRef Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 2002; 53: 678–87. PubMedCrossRef
19.
go back to reference Tada H, Sticherling C, Cough SP, Baker RL, Wasmer K, Daoud EG, et al. Gender and age differences in induced atrial fibrillation. Am J Cardiol 2001; 88: 436–38. PubMedCrossRef Tada H, Sticherling C, Cough SP, Baker RL, Wasmer K, Daoud EG, et al. Gender and age differences in induced atrial fibrillation. Am J Cardiol 2001; 88: 436–38. PubMedCrossRef
20.
go back to reference Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europa: a report from the euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572–77. PubMedCrossRef Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europa: a report from the euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572–77. PubMedCrossRef
21.
go back to reference Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk ofdeath: the Framingham Heart Study. Circulation 1998; 98: 946–52. PubMedCrossRef Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk ofdeath: the Framingham Heart Study. Circulation 1998; 98: 946–52. PubMedCrossRef
22.
go back to reference Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on AF. Chest 2010; 137: 263–72. PubMedCrossRef Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on AF. Chest 2010; 137: 263–72. PubMedCrossRef
23.
go back to reference Alings AMW. Preventie van CVA bij boezemfibrilleren. Hartbulletin 2011; 42: 30–33. Alings AMW. Preventie van CVA bij boezemfibrilleren. Hartbulletin 2011; 42: 30–33.
24.
go back to reference Ten Cate H. Farmacologie van nieuwe orale anticoagulantia. Hartbulletin 2011; 42: 40–43. Ten Cate H. Farmacologie van nieuwe orale anticoagulantia. Hartbulletin 2011; 42: 40–43.
25.
go back to reference Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcome and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167–72. PubMedCrossRef Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcome and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167–72. PubMedCrossRef
26.
go back to reference Suttorp MJ, Kingma H, Koomen EM, HofA van ‘t, Tijssen JE, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71: 710-13. PubMedCrossRef Suttorp MJ, Kingma H, Koomen EM, HofA van ‘t, Tijssen JE, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71: 710-13. PubMedCrossRef
27.
go back to reference Benito B, Sarkozy A, Mont L,Henkens S, Berruezo A, Tamborero D, Arzamendi D, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008; 52: 1567–73. PubMedCrossRef Benito B, Sarkozy A, Mont L,Henkens S, Berruezo A, Tamborero D, Arzamendi D, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008; 52: 1567–73. PubMedCrossRef
29.
go back to reference Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, et al. Risk stratification in the long-QT syndrome. N Eng J Med 2003; 348: 1866–74. CrossRef Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, et al. Risk stratification in the long-QT syndrome. N Eng J Med 2003; 348: 1866–74. CrossRef
30.
go back to reference Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ, Andrews M, for the LQTS investigators. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 1998; 97: 451–56. PubMedCrossRef Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ, Andrews M, for the LQTS investigators. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 1998; 97: 451–56. PubMedCrossRef
31.
go back to reference Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation 1996; 93: 1170-76. PubMedCrossRef Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation 1996; 93: 1170-76. PubMedCrossRef
32.
go back to reference Kannel WB, Wilson PWF, D’Agostino RB. Sudden coronary death in women. Am Heart J 1998; 136: 205-12. PubMedCrossRef Kannel WB, Wilson PWF, D’Agostino RB. Sudden coronary death in women. Am Heart J 1998; 136: 205-12. PubMedCrossRef
33.
go back to reference Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004; 25: 88–95. PubMedCrossRef Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004; 25: 88–95. PubMedCrossRef
34.
go back to reference Lamas GA, Pashos CL, Normand SL, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063–69. PubMedCrossRef Lamas GA, Pashos CL, Normand SL, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063–69. PubMedCrossRef
35.
go back to reference Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace 2010; 12: 210–15. PubMedCrossRef Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace 2010; 12: 210–15. PubMedCrossRef
36.
go back to reference Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Peiper K, Buxton AE. mustt Investigators. Influence of gender on arrhythmia characteristics and outcome in the Multicenter Unsustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15: 993–98. PubMedCrossRef Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Peiper K, Buxton AE. mustt Investigators. Influence of gender on arrhythmia characteristics and outcome in the Multicenter Unsustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15: 993–98. PubMedCrossRef
37.
go back to reference Zareba W, Moss AJ, Hall WJ, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. MADIT II Investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarct women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16: 1265–70. PubMedCrossRef Zareba W, Moss AJ, Hall WJ, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. MADIT II Investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarct women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16: 1265–70. PubMedCrossRef
38.
go back to reference Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee Kl, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: Results from the sudden cardiac death in heart failure trial. J Cardiovasc Electrophysiol 2008; 19: 720–24. PubMedCrossRef Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee Kl, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: Results from the sudden cardiac death in heart failure trial. J Cardiovasc Electrophysiol 2008; 19: 720–24. PubMedCrossRef
39.
go back to reference Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010; 7: 876–82. PubMedCrossRef Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010; 7: 876–82. PubMedCrossRef
40.
go back to reference Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517–24. PubMedCrossRef Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517–24. PubMedCrossRef
41.
go back to reference Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect ofcardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–49. PubMedCrossRef Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect ofcardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–49. PubMedCrossRef
42.
go back to reference Moss AJ, Hall WJ, Cannon DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Eng J Med 2009; 361: 1329–38. CrossRef Moss AJ, Hall WJ, Cannon DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Eng J Med 2009; 361: 1329–38. CrossRef
Metagegevens
Titel
Genderspecifieke Aspecten van Hartritmestoornissen
Auteurs
Drs. Lieve van Casteren
Dr. Arif Elvan
Drs. Amber Otten
Drs. Bernadette van Casteren
Copyright
2011
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8782-3_5